Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.31

(-2.24%)

Revenue Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual revenue in 2023 was 1.37 Billion USD , up 9.46% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly revenue in 2024 Q2 was 342.28 Million USD , up 1.42% from previous quarter.
  • Curaleaf Holdings, Inc. reported a annual revenue of 1.66 Billion USD in annual revenue 2022, up 10.73% from previous year.
  • Curaleaf Holdings, Inc. reported a annual revenue of 1.49 Billion USD in annual revenue 2021, up 78.4% from previous year.
  • Curaleaf Holdings, Inc. reported a quarterly revenue of 457.08 Million USD for 2024 Q1, down -4.9% from previous quarter.
  • Curaleaf Holdings, Inc. reported a quarterly revenue of 446.87 Million USD for 2023 Q3, down -1.73% from previous quarter.

Annual Revenue Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Historical Annual Revenue of Curaleaf Holdings, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 1.37 Billion USD 9.46%
2022 1.66 Billion USD 10.73%
2021 1.49 Billion USD 78.4%
2020 840.5 Million USD 186.6%
2019 293.26 Million CAD 193.63%
2018 99.87 Million CAD 298.42%
2017 25.06 Million CAD 0.0%
2016 - CAD 0.0%

Peer Revenue Comparison of Curaleaf Holdings, Inc.

Name Revenue Revenue Difference
Aurora Cannabis Inc. 270.28 Million CAD -407.371%
Avicanna Inc. 16.79 Million CAD -8066.805%
Avant Brands Inc. 26.34 Million CAD -5105.465%
Cardiol Therapeutics Inc. - CAD -Infinity%
Crescita Therapeutics Inc. 17.52 Million CAD -7726.319%
Knight Therapeutics Inc. 328.19 Million CAD -317.834%
MediPharm Labs Corp. 33.06 Million CAD -4047.746%
OrganiGram Holdings Inc. 149.2 Million CAD -819.088%
Canopy Growth Corporation 297.14 Million CAD -361.5%
Willow Biosciences Inc. 1.17 Million CAD -116907.477%
Auxly Cannabis Group Inc. 101.07 Million CAD -1256.702%